Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Focal Point Pharmaceuticals

Focal Point Pharmaceuticals
2013 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$80K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of products designed to treat ocular diseases. The company's products are developed with pre-clinical research and lead selection, enabling clients to treat rare diseases, including ocular trauma and other eye diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 40 South Main Street
  • Suite 2300
  • Memphis, TN 38103
  • United States

+1 (484) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Focal Point Pharmaceuticals’s full profile, request a free trial.

Focal Point Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 31-Jan-2017 $80K 00000 Completed Generating Revenue
2. Early Stage VC 14-Aug-2013 00000 00000 Completed Generating Revenue
1. Grant Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Focal Point Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
MB Venture Partners Venture Capital Minority 000 0000 000000 0

Focal Point Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Edward Chaum MD Co-Founder & Chief Scientific Officer
Gary Prosterman Treasurer & Board Member
Raymond Hage Jr. President & Board Member

Focal Point Pharmaceuticals Board Members (3)

Name Representing Role Since Contact
Info
Gary Prosterman Focal Point Pharmaceuticals Treasurer & Board Member 000 0000
Gary Stevenson MB Venture Partners Board Member 000 0000
Raymond Hage Jr. Self President & Board Member 000 0000